212 related articles for article (PubMed ID: 23037715)
1. Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.
Tawadros T; Brown MD; Hart CA; Clarke NW
Br J Cancer; 2012 Nov; 107(10):1737-44. PubMed ID: 23037715
[TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer.
Brown M; Roulson JA; Hart CA; Tawadros T; Clarke NW
Br J Cancer; 2014 Apr; 110(8):2099-108. PubMed ID: 24595005
[TBL] [Abstract][Full Text] [Related]
3. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis.
Taddei ML; Parri M; Angelucci A; Onnis B; Bianchini F; Giannoni E; Raugei G; Calorini L; Rucci N; Teti A; Bologna M; Chiarugi P
Am J Pathol; 2009 Apr; 174(4):1492-503. PubMed ID: 19264906
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells.
Yang NY; Fernandez C; Richter M; Xiao Z; Valencia F; Tice DA; Pasquale EB
Cell Signal; 2011 Jan; 23(1):201-12. PubMed ID: 20837138
[TBL] [Abstract][Full Text] [Related]
5. EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility.
Parri M; Buricchi F; Giannoni E; Grimaldi G; Mello T; Raugei G; Ramponi G; Chiarugi P
J Biol Chem; 2007 Jul; 282(27):19619-28. PubMed ID: 17449913
[TBL] [Abstract][Full Text] [Related]
6. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
[TBL] [Abstract][Full Text] [Related]
7. Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility.
Chen Z; Oh D; Biswas KH; Yu CH; Zaidel-Bar R; Groves JT
Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5696-E5705. PubMed ID: 29866846
[TBL] [Abstract][Full Text] [Related]
8. Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer.
Sachdeva A; Hart CA; Kim K; Tawadros T; Oliveira P; Shanks J; Brown M; Clarke N
Br J Cancer; 2022 Oct; 127(7):1254-1262. PubMed ID: 35869144
[TBL] [Abstract][Full Text] [Related]
9. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.
Miao H; Li DQ; Mukherjee A; Guo H; Petty A; Cutter J; Basilion JP; Sedor J; Wu J; Danielpour D; Sloan AE; Cohen ML; Wang B
Cancer Cell; 2009 Jul; 16(1):9-20. PubMed ID: 19573808
[TBL] [Abstract][Full Text] [Related]
10. Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells.
Navarro-Tito N; Robledo T; Salazar EP
Exp Cell Res; 2008 Nov; 314(18):3340-55. PubMed ID: 18804105
[TBL] [Abstract][Full Text] [Related]
11. Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer.
Brown MD; Hart C; Gazi E; Gardner P; Lockyer N; Clarke N
Br J Cancer; 2010 Jan; 102(2):403-13. PubMed ID: 19997104
[TBL] [Abstract][Full Text] [Related]
12. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
Wykosky J; Debinski W
Mol Cancer Res; 2008 Dec; 6(12):1795-806. PubMed ID: 19074825
[TBL] [Abstract][Full Text] [Related]
13. EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts.
Giannoni E; Taddei ML; Parri M; Bianchini F; Santosuosso M; Grifantini R; Fibbi G; Mazzanti B; Calorini L; Chiarugi P
J Mol Med (Berl); 2013 Jan; 91(1):103-15. PubMed ID: 22903544
[TBL] [Abstract][Full Text] [Related]
14. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
[TBL] [Abstract][Full Text] [Related]
15. Arachidonic acid promotes migration and invasion through a PI3K/Akt-dependent pathway in MDA-MB-231 breast cancer cells.
Villegas-Comonfort S; Castillo-Sanchez R; Serna-Marquez N; Cortes-Reynosa P; Salazar EP
Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):169-77. PubMed ID: 24565443
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-Producing Hepatoma Receptor Tyrosine Kinase A2 Modulation Associates with Protective Effect of Prone Position in Ventilator-induced Lung Injury.
Park BH; Shin MH; Douglas IS; Chung KS; Song JH; Kim SY; Kim EY; Jung JY; Kang YA; Chang J; Kim YS; Park MS
Am J Respir Cell Mol Biol; 2018 Apr; 58(4):519-529. PubMed ID: 29216437
[TBL] [Abstract][Full Text] [Related]
17. EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration.
Kaplan N; Fatima A; Peng H; Bryar PJ; Lavker RM; Getsios S
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):936-45. PubMed ID: 22247486
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion and EGFR activation regulate EphA2 expression in cancer.
Larsen AB; Stockhausen MT; Poulsen HS
Cell Signal; 2010 Apr; 22(4):636-44. PubMed ID: 19948216
[TBL] [Abstract][Full Text] [Related]
19. Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation.
Yang XY; Zhu WJ; Jiang H
Mol Cell Biochem; 2012 Feb; 361(1-2):259-65. PubMed ID: 22009484
[TBL] [Abstract][Full Text] [Related]
20. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
